Advertisement

Divergence of Iodine and Thyroid Hormones in the Fetal and Maternal Parts of Human-Term Placenta

  • Shiqiao Peng
  • Chenyan Li
  • Xiaochen Xie
  • Xiaomei Zhang
  • Danyang Wang
  • Xixuan Lu
  • Manni Sun
  • Tao Meng
  • Shiwei Wang
  • Yaqiu Jiang
  • Zhongyan Shan
  • Weiping TengEmail author
Article
  • 55 Downloads

Abstract

The human placenta is an important organ that forms a barrier where maternal and fetal exchange takes place. The placenta transport iodine to the fetal circulation by transfer of maternal iodine and deiodination of thyroid hormones (THs). The aim of the study was to examine the distribution of iodine and thyroid hormone transporters in the maternal and fetal sides of human-term placenta. A cross-sectional study was performed at the First Affiliated Hospital of China Medical University. Placental samples (maternal and fetal surfaces) were collected from 113 healthy-term pregnant women. The iodine content; the concentration of thyroxine (T4), triiodothyronine (T3), and reverse T3 (rT3); and the enzyme activity of placental type 2 iodothyronine deiodinase (D2) and D3 were examined. The mRNA and protein localization/expression of iodine and thyroid hormone transporters in the placenta were also studied. We also analyzed the association between expression level of Na+/I− symporter (NIS), thyroid hormone transporter protein, D3 activity in maternal and fetal surfaces of placenta with iodine content, and thyroid hormone levels. Iodine levels in placental samples from the maternal side were significantly higher than those in samples from the fetal side. T3 and T4 expression in fetal placenta was significantly lower than in maternal placenta. D3 activity in the fetal side of the placentas was significantly higher than that in the maternal side. The mRNA and protein expression of monocarboxylate transporters 8 (MCT8), L-amino acid transporters 1 (LAT1), organic anion transporting polypeptides 4A1 (OATP4A1), and TH binding protein transthyretin (TTR) were significantly increased in maternal side, while the NIS expression was higher in fetal side of human-term placenta. In conclusion, the enzymatic deiodination of thyroid hormones forms a barrier which reduces transplacental passage of the hormones and that the maternal part of the placenta is the primary factor in the mechanism regulating the hormonal transfer.

Keywords

Iodine Thyroid hormone transporter Maternal placenta Fetal placenta Deiodination 

Notes

Authors’ Contributions

SP and CL performed the experimental work, analyzed the results, and composed the manuscript. XX, XZ, and DW performed the study and collected the samples. XL reviewed and edited the manuscript. MS and TM participated in the experiments. SW and YJ collected the general information of study populations and contributed to the interpretation and analysis of data; ZS helped with coordination of this study; WT supervised the statistical analyses; contributed to the design of the study, analyses, and interpretation of the results; and produced the final version of the manuscript.

Funding information

This study was funded by the Chinese National Science Foundation (grant numbers 81170730, 81570709, 81670719) and 973 Plan preliminary research project (2011CB512112).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Glinoer D (1997) The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18(3):404–433.  https://doi.org/10.1210/edrv.18.3.0300 CrossRefGoogle Scholar
  2. 2.
    Delange F (2001) Iodine deficiency as a cause of brain damage. Postgrad Med J 77(906):217–220CrossRefGoogle Scholar
  3. 3.
    Delange F (1998) Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control. Thyroid 8(12):1185–1192.  https://doi.org/10.1089/thy.1998.8.1185 CrossRefGoogle Scholar
  4. 4.
    Moleti M, Trimarchi F, Vermiglio F (2014) Thyroid physiology in pregnancy. Endocr Pract 20(6):589–596.  https://doi.org/10.4158/EP13341.RA CrossRefGoogle Scholar
  5. 5.
    Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, Bellet D, Filetti S, Schlumberger M (2000) Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 85(11):4367–4372.  https://doi.org/10.1210/jcem.85.11.6969 Google Scholar
  6. 6.
    Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH (2001) Sodium iodide symporter (NIS) gene expression in human placenta. Placenta 22(2–3):256–258.  https://doi.org/10.1053/plac.2000.0609 CrossRefGoogle Scholar
  7. 7.
    Di Cosmo C, Fanelli G, Tonacchera M, Ferrarini E, Dimida A, Agretti P, De Marco G, Vitti P, Pinchera A, Bevilacqua G, Naccarato AG, Viacava P (2006) The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study. Clin Endocrinol 65(4):544–548.  https://doi.org/10.1111/j.1365-2265.2006.02577.x CrossRefGoogle Scholar
  8. 8.
    Manley SW, Li H, Mortimer RH (2005) The BeWo choriocarcinoma cell line as a model of iodide transport by placenta. Placenta 26(5):380–386.  https://doi.org/10.1016/j.placenta.2004.07.004 CrossRefGoogle Scholar
  9. 9.
    Bernal J (2007) Thyroid hormone receptors in brain development and function. Nature clinical practice. Endocrinol Metab 3(3):249–259.  https://doi.org/10.1038/ncpendmet0424 Google Scholar
  10. 10.
    Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, Ris-Stalpers C, Kok JH, Vulsma T, Boer K, Visser TJ (1996) Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab 81(6):2154–2158.  https://doi.org/10.1210/jcem.81.6.8964844 Google Scholar
  11. 11.
    Salvatore D, Bartha T, Harney JW, Larsen PR (1996) Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137(8):3308–3315.  https://doi.org/10.1210/endo.137.8.8754756 CrossRefGoogle Scholar
  12. 12.
    Kohrle J (1999) Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 151(1–2):103–119CrossRefGoogle Scholar
  13. 13.
    Chan S, Kachilele S, Hobbs E, Bulmer JN, Boelaert K, McCabe CJ, Driver PM, Bradwell AR, Kester M, Visser TJ, Franklyn JA, Kilby MD (2003) Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab 88(9):4488–4495.  https://doi.org/10.1210/jc.2003-030228 CrossRefGoogle Scholar
  14. 14.
    Grumbach MM, Werner SC (1956) Transfer of thyroid hormone across the human placenta at term. J Clin Endocrinol Metab 16(10):1392–1395.  https://doi.org/10.1210/jcem-16-10-1392 CrossRefGoogle Scholar
  15. 15.
    Vulsma T, Gons MH, de Vijlder JJ (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321(1):13–16.  https://doi.org/10.1056/NEJM198907063210103 CrossRefGoogle Scholar
  16. 16.
    James SR, Franklyn JA, Kilby MD (2007) Placental transport of thyroid hormone. Best practice and research. Clin Endocrinol Metab 21(2):253–264.  https://doi.org/10.1016/j.beem.2007.03.001 Google Scholar
  17. 17.
    Chan SY, Vasilopoulou E, Kilby MD (2009) The role of the placenta in thyroid hormone delivery to the fetus. Nature clinical practice. Endocrinol Metab 5(1):45–54.  https://doi.org/10.1038/ncpendmet1026 Google Scholar
  18. 18.
    Landers KA, McKinnon BD, Li H, Subramaniam VN, Mortimer RH, Richard K (2009) Carrier-mediated thyroid hormone transport into placenta by placental transthyretin. J Clin Endocrinol Metab 94(7):2610–2616.  https://doi.org/10.1210/jc.2009-0048 CrossRefGoogle Scholar
  19. 19.
    Sato K, Sugawara J, Sato T, Mizutamari H, Suzuki T, Ito A, Mikkaichi T, Onogawa T, Tanemoto M, Unno M, Abe T, Okamura K (2003) Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta 24(2–3):144–148CrossRefGoogle Scholar
  20. 20.
    Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, McCabe CJ, Kilby MD (2006) Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol 189(3):465–471.  https://doi.org/10.1677/joe.1.06582 CrossRefGoogle Scholar
  21. 21.
    Kinne A, Kleinau G, Hoefig CS, Gruters A, Kohrle J, Krause G, Schweizer U (2010) Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem 285(36):28054–28063.  https://doi.org/10.1074/jbc.M110.129577
  22. 22.
    van Mullem AA, van Gucht ALM, Visser WE, Meima ME, Peeters RP, Visser TJ (2016) Effects of thyroid hormone transporters MCT8 and MCT10 on nuclear activity of T3. Mol Cell Endocrinol 437:252–260.  https://doi.org/10.1016/j.mce.2016.07.037 CrossRefGoogle Scholar
  23. 23.
    Ritchie JW, Taylor PM (2001) Role of the system L permease LAT1 in amino acid and iodothyronine transport in placenta. Biochem J 356(Pt 3):719–725CrossRefGoogle Scholar
  24. 24.
    Landers KA, Li H, Subramaniam VN, Mortimer RH, Richard K (2013) Transthyretin-thyroid hormone internalization by trophoblasts. Placenta 34(8):716–718.  https://doi.org/10.1016/j.placenta.2013.05.005 CrossRefGoogle Scholar
  25. 25.
    McKinnon B, Li H, Richard K, Mortimer R (2005) Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast. J Clin Endocrinol Metab 90(12):6714–6720.  https://doi.org/10.1210/jc.2005-0696 CrossRefGoogle Scholar
  26. 26.
    Patel J, Landers KA, Li H, Mortimer RH, Richard K (2011) Ontogenic changes in placental transthyretin. Placenta 32(11):817–822.  https://doi.org/10.1016/j.placenta.2011.09.007 CrossRefGoogle Scholar
  27. 27.
    Reyns GE, Janssens KA, Buyse J, Kuhn ER, Darras VM (2002) Changes in thyroid hormone levels in chicken liver during fasting and refeeding. Comp Biochem Physiol B Biochem Mol Biol 132(1):239–245CrossRefGoogle Scholar
  28. 28.
    Reyns GE, Verhoelst CH, Kuhn ER, Darras VM, Van der Geyten S (2005) Regulation of thyroid hormone availability in liver and brain by glucocorticoids. Gen Comp Endocrinol 140(2):101–108.  https://doi.org/10.1016/j.ygcen.2004.10.006 CrossRefGoogle Scholar
  29. 29.
    Castro MI, Braverman LE, Alex S, Wu CF, Emerson CH (1985) Inner-ring deiodination of 3,5,3′-triiodothyronine in the in situ perfused guinea pig placenta. J Clin Invest 76(5):1921–1926.  https://doi.org/10.1172/JCI112188 CrossRefGoogle Scholar
  30. 30.
    Obregon MJ, Ruiz de Ona C, Hernandez A, Calvo R, Escobar del Rey F, Morreale de Escobar G (1989) Thyroid hormones and 5′-deiodinase in rat brown adipose tissue during fetal life. Am J Phys 257(5 Pt 1):E625–E631.  https://doi.org/10.1152/ajpendo.1989.257.5.E625 Google Scholar
  31. 31.
    Hernandez A, Obregon MJ (1995) Presence of growth factors-induced type III iodothyronine 5-deiodinase in cultured rat brown adipocytes. Endocrinology 136(10):4543–4550.  https://doi.org/10.1210/endo.136.10.7664675 CrossRefGoogle Scholar
  32. 32.
    Burns R, O'Herlihy C, Smyth PP (2013) Regulation of iodide uptake in placental primary cultures. Eur Thyroid J 2(4):243–251.  https://doi.org/10.1159/000356847 CrossRefGoogle Scholar
  33. 33.
    Li H, Patel J, Mortimer RH, Richard K (2012) Ontogenic changes in human placental sodium iodide symporter expression. Placenta 33(11):946–948.  https://doi.org/10.1016/j.placenta.2012.08.002 CrossRefGoogle Scholar
  34. 34.
    Schroder-van der Elst JP, van der Heide D, Kastelijn J, Rousset B, Obregon MJ (2001) The expression of the sodium/iodide symporter is up-regulated in the thyroid of fetuses of iodine-deficient rats. Endocrinology 142(9):3736–3741.  https://doi.org/10.1210/endo.142.9.8377 CrossRefGoogle Scholar
  35. 35.
    Mortimer RH, Galligan JP, Cannell GR, Addison RS, Roberts MS (1996) Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. J Clin Endocrinol Metab 81(6):2247–2249.  https://doi.org/10.1210/jcem.81.6.8964859 Google Scholar
  36. 36.
    Cooper E, Gibbens M, Thomas CR, Lowy C, Burke CW (1983) Conversion of thyroxine to 3,3′,5′-triiodothyronine in the guinea pig placenta: in vivo studies. Endocrinology 112(5):1808–1815.  https://doi.org/10.1210/endo-112-5-1808 CrossRefGoogle Scholar
  37. 37.
    Kurlak LO, Mistry HD, Kaptein E, Visser TJ, Broughton Pipkin F (2013) Thyroid hormones and their placental deiodination in normal and pre-eclamptic pregnancy. Placenta 34(5):395–400.  https://doi.org/10.1016/j.placenta.2013.02.009 CrossRefGoogle Scholar
  38. 38.
    Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P, Magnusson B (1982) A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol 101(4):531–537CrossRefGoogle Scholar
  39. 39.
    Laurberg P, Andersen SL, Pedersen IB, Andersen S, Carle A (2013) Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests. Clin Endocrinol 79(3):297–304.  https://doi.org/10.1111/cen.12232 CrossRefGoogle Scholar
  40. 40.
    Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR (2003) Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 88(3):1384–1388.  https://doi.org/10.1210/jc.2002-021291 CrossRefGoogle Scholar
  41. 41.
    Steinsapir J, Bianco AC, Buettner C, Harney J, Larsen PR (2000) Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Endocrinology 141(3):1127–1135.  https://doi.org/10.1210/endo.141.3.7355 CrossRefGoogle Scholar
  42. 42.
    Akturk M, Oruc AS, Danisman N, Erkek S, Buyukkagnici U, Unlu E, Tazebay UH (2013) Na+/I- symporter and type 3 iodothyronine deiodinase gene expression in amniotic membrane and placenta and its relationship to maternal thyroid hormones. Biol Trace Elem Res 154(3):338–344.  https://doi.org/10.1007/s12011-013-9748-y CrossRefGoogle Scholar
  43. 43.
    Perez-Lopez FR (2007) Iodine and thyroid hormones during pregnancy and postpartum. Gynecol Endocrinol 23(7):414–428.  https://doi.org/10.1080/09513590701464092 CrossRefGoogle Scholar
  44. 44.
    Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, McCabe CJ, Franklyn JA, Kilby MD, Chan SY (2010) Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta 31(4):295–304.  https://doi.org/10.1016/j.placenta.2010.01.013 CrossRefGoogle Scholar
  45. 45.
    Cleal JK, Glazier JD, Ntani G, Crozier SR, Day PE, Harvey NC, Robinson SM, Cooper C, Godfrey KM, Hanson MA, Lewis RM (2011) Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast. J Physiol 589(Pt 4):987–997.  https://doi.org/10.1113/jphysiol.2010.198549 CrossRefGoogle Scholar
  46. 46.
    Prasad PD, Wang H, Huang W, Kekuda R, Rajan DP, Leibach FH, Ganapathy V (1999) Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 255(2):283–288.  https://doi.org/10.1006/bbrc.1999.0206 CrossRefGoogle Scholar
  47. 47.
    Gaccioli F, Aye IL, Roos S, Lager S, Ramirez VI, Kanai Y, Powell TL, Jansson T (2015) Expression and functional characterisation of system L amino acid transporters in the human term placenta. Reprod Biol Endocrinol 13:57.  https://doi.org/10.1186/s12958-015-0054-8 CrossRefGoogle Scholar
  48. 48.
    Hoeltzli SD, Smith CH (1989) Alanine transport systems in isolated basal plasma membrane of human placenta. Am J Phys 256(3 Pt 1):C630–C637.  https://doi.org/10.1152/ajpcell.1989.256.3.C630 CrossRefGoogle Scholar
  49. 49.
    Lewis RM, Glazier J, Greenwood SL, Bennett EJ, Godfrey KM, Jackson AA, Sibley CP, Cameron IT, Hanson MA (2007) L-serine uptake by human placental microvillous membrane vesicles. Placenta 28(5–6):445–452.  https://doi.org/10.1016/j.placenta.2006.06.014 CrossRefGoogle Scholar
  50. 50.
    Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Asano N, Tanemoto M, Seki M, Shiiba K, Suzuki M, Kondo Y, Nunoki K, Shimosegawa T, Iinuma K, Ito S, Matsuno S, Abe T (2001) Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 142(5):2005–2012.  https://doi.org/10.1210/endo.142.5.8115 CrossRefGoogle Scholar
  51. 51.
    Sun X, Lu L, Shan L, Shan Z, Teng W (2017) Iodine storage and metabolism of mild to moderate iodine-deficient pregnant rats. Thyroid 27(6):846–851.  https://doi.org/10.1089/thy.2016.0611 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Shiqiao Peng
    • 1
  • Chenyan Li
    • 1
  • Xiaochen Xie
    • 1
  • Xiaomei Zhang
    • 2
  • Danyang Wang
    • 3
  • Xixuan Lu
    • 1
  • Manni Sun
    • 4
  • Tao Meng
    • 4
  • Shiwei Wang
    • 1
  • Yaqiu Jiang
    • 1
  • Zhongyan Shan
    • 1
  • Weiping Teng
    • 1
    Email author
  1. 1.Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical UniversityChina Medical UniversityShenyangPeople’s Republic of China
  2. 2.Department of Endocrinology and MetabolismPeking University International HospitalBeijingPeople’s Republic of China
  3. 3.Department of Endocrinology and MetabolismThe First Hospital of DandongDandongPeople’s Republic of China
  4. 4.Department of Obstetrics, The First Affiliated Hospital of China Medical UniversityChina Medical UniversityShenyangPeople’s Republic of China

Personalised recommendations